PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.04%
Revenue growth under 50% of AVGO's 9.97%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
0.29%
Gross profit growth under 50% of AVGO's 10.28%. Michael Burry would be concerned about a severe competitive disadvantage.
0.32%
EBIT growth below 50% of AVGO's 9.02%. Michael Burry would suspect deeper competitive or cost structure issues.
-0.96%
Negative operating income growth while AVGO is at 9.02%. Joel Greenblatt would press for urgent turnaround measures.
297.09%
Net income growth under 50% of AVGO's 879.56%. Michael Burry would suspect the firm is falling well behind a key competitor.
294.29%
EPS growth under 50% of AVGO's 850.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
297.06%
Diluted EPS growth under 50% of AVGO's 873.33%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.20%
Share reduction while AVGO is at 0.49%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.20%
Reduced diluted shares while AVGO is at 0.47%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.20%
Dividend growth under 50% of AVGO's 80.61%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-42.35%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-45.64%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
56.33%
10Y revenue/share CAGR under 50% of AVGO's 655.55%. Michael Burry would suspect a lasting competitive disadvantage.
47.90%
5Y revenue/share CAGR under 50% of AVGO's 454.90%. Michael Burry would suspect a significant competitive gap or product weakness.
27.80%
3Y revenue/share CAGR under 50% of AVGO's 102.64%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
134.19%
10Y OCF/share CAGR under 50% of AVGO's 22087.20%. Michael Burry would worry about a persistent underperformance in cash creation.
247.85%
5Y OCF/share CAGR at 50-75% of AVGO's 446.49%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
94.00%
3Y OCF/share CAGR at 75-90% of AVGO's 117.88%. Bill Ackman would press for improvements in margin or overhead to catch up.
178.55%
Below 50% of AVGO's 54095.93%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
324.95%
Below 50% of AVGO's 2890.40%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
121.24%
Below 50% of AVGO's 1003.92%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
45.75%
Equity/share CAGR of 45.75% while AVGO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
9.43%
Below 50% of AVGO's 517.18%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
9.04%
Below 50% of AVGO's 344.02%. Michael Burry suspects a serious short-term disadvantage in building book value.
520.16%
Dividend/share CAGR of 520.16% while AVGO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
196.58%
Below 50% of AVGO's 978.57%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
82.35%
Below 50% of AVGO's 427.61%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
13.77%
AR growth well above AVGO's 0.45%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.83%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-0.77%
Negative asset growth while AVGO invests at 0.23%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.16%
Under 50% of AVGO's 24.22%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
0.02%
Debt shrinking faster vs. AVGO's 0.25%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-0.26%
Our R&D shrinks while AVGO invests at 11.71%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
5.87%
SG&A declining or stable vs. AVGO's 50.00%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.